22 Nov 2024
Working on advanced #antiviral strategies, #biomedical engineering and #therapeutic approaches to combat viral #infections?🔬🦠Join online discussions by 1⃣6⃣:3⃣0⃣ today with #researchers and #innovators in #academia and #industry incl. from @ProtzerLab at the @Virofight event!⬇️
11 Oct 2024
We have exciting news🤩
Join our hybrid #VIROFIGHTSymposium on #Antiviral Biologics!
Explore cutting-edge research and innovations in the fight against viral infections with top experts.
📅22.Nov 2024
📍Garching 🇩🇪 & online
✍️Register now: virofight.eu/virofight-sympo…
Stay tuned🌟
2
9
752
9 Sep 2024
Congratulations to Sophia Schreiber (@ProtzerLab) and Lisa S. Dessler (@TU_Muenchen) for winning the #PaperOfTheQuarter award presented by @DGGTeV.
Read their work on CARs targeting hepatitis B virus infected cells ⬇️
2
5
852
29 Aug 2024
The #DGGTeV is delighted to present Sophia Schreiber and Lisa S. Dessler from @ProtzerLab at the @TU_Muenchen the #PaperoftheQuarter #Award for their work to engineer CARs from sorted B cells targeting Hepatitis B.
more here:
dg-gt.de/paper-of-the-quarte…
1
4
189
23rd workshop of the #jGfV study group "Immunobiology to viral infection" 28.-30.10.24 in Bad Salzschlirf. Deadline September 1st! Great keynote speakers: @janis_mue11er, Hannes Vietzen @MedUni_Wien, Anna Kosinska @ProtzerLab for the @TherVacB_EU
immunviro.g-f-v.org/ (HMB)
1
6
12
2,445
Happy that our joint article with Ulrike Protzer's lab (@ProtzerLab) on the use of AAV vectors for development of HBV mouse models is now out: pubmed.ncbi.nlm.nih.gov/3904… Congrats to 1st author Lisa Schiller, our former MSc student & now PhD student in the Protzer lab 🎊🥂 #AAV #HBV
1
2
5
416
1 May 2024
Nice read for everyone interested in HBV immunology and the role of HBsAg.
Congrats @ProtzerLab @UlrikeProtzer !
The lack of HBsAg secretion does neither facilitate induction of antiv... sciencedirect.com/science/ar…
4
9
1,116
18 Mar 2024
𝗦𝗰𝗵𝘂𝘁𝘇 𝘃𝗼𝗿 𝗣𝗮𝗻𝗱𝗲𝗺𝗶𝗲𝗻 𝗱𝗮𝗻𝗸 𝗔𝘂𝗴𝘀𝗯𝘂𝗿𝗴𝗲𝗿 𝗛𝗶𝗴𝗵𝘁𝗲𝗰𝗵-𝗟𝗮𝗯𝗼𝗿
Mehr zur Labor-Eröffnung & zum EU-Projekt PerForM-REACT:
👉t1p.de/szwee
@Traidl_Hoffmann @UlrikeProtzer @IEM_Augsburg
@ProtzerLab @uni__augsburg #HelmholtzMunich
12 Mar 2024
Am Montag wurde im Rahmen des EU-geförderten Projekts „PerForM-REACT“ zur Pandemievorsorge die Erweiterung des Sicherheitslabors in Augsburg eröffnet. Es ermöglicht die Forschung mit modernster Hightech-Infrastruktur.
presse-augsburg.de/perform-r…
ALT PRESSE AUGSBURG
5
911
11 Mar 2024
Schutz vor Pandemien: Heute wurde ein modernes Hightech-Labor in Augsburg eröffnet!
Mehr zum EU-Projekt PerForM-REACT:
👉t1p.de/szwee
@Traidl_Hoffmann @UlrikeProtzer @IEM_Augsburg @ProtzerLab @uni__augsburg #EFRE
Impressionen im Video 👇
📷Ulrich Wirth
4
7
1,505
2 Feb 2024
Hope you are ready for our kick-off meeting #MunichRNA21F! Come and hear the great research by @shu_bhayankar from @ProtzerLab and @AlexKarollus from @gagneurlab . See you very soon!
📅21F 3pm
📍@HelmholtzMunich
7
19
2,313
Follow our latest 👩🔬 #WomenAtHelmholtzMunich 👩💼 stories on #Instagram 👉 t1p.de/7j275 & find out what the researchers at #HelmholtzMunich think.
@MarionJasnin @lauradmartens @OBond10 @UlrikeProtzer @ProtzerLab @LaraUrban42
@emutius @helmholtz_de
6
13
1,677
27 Jan 2023
Looking forward to two days full of hepatology, science and meeting fellow liver enthusiasts at #GASL annual meeting @ruhrunibochum ✨🤩🤓✨ @KnolleLab @ProtzerLab @teximmed2
6
488
20 Jan 2023
Automated detection of neutralizing #SARSCoV2 antibodies in minutes using a competitive #chemiluminescence immunoassay
by Michael Seidel @UlrikeProtzer et al @TU_Muenchen @ProtzerLab @HelmholtzMunich @KnolleLab @DZIF_ #COVID19
#OpenAccess
link.springer.com/article/10…
3
5
1,216
16 Jan 2023
👏💉A #vaccine against #hepatitisB:
A team @ProtzerLab from #HelmholtzMunich, @TU_Muenchen & @DZIF_ had exciting insights!
❓Do you want to know more about the research from @UlrikeProtzer❓
📽️Watch the 𝘃𝗶𝗱𝗲𝗼 below!
🔴Check out the latest News:
👉t1p.de/p9bt2
3
7
1,948
10 Jan 2023
Wir sind stolz darauf einen Schlüsselfaktor für eine erfolgreiche therapeutische Impfung identifiziert zu haben! Danke an das großartige Team und unsere Partner! #DZIF #ProtzerLab #PercyKnolle
10 Jan 2023
🎉Congrats! A team @ProtzerLab around @UlrikeProtzer from @HelmholtzMunich, @TU_Muenchen & @DZIF_ discovered that the success of therapeutic #HepatitisB vaccination depends on efficient priming of #HBV-specific CD4 T cells.
👉Check out the new publication: t1p.de/p9bt2
2
1
18
2,351
10 Jan 2023
🎉Congrats! A team @ProtzerLab around @UlrikeProtzer from @HelmholtzMunich, @TU_Muenchen & @DZIF_ discovered that the success of therapeutic #HepatitisB vaccination depends on efficient priming of #HBV-specific CD4 T cells.
👉Check out the new publication: t1p.de/p9bt2
1
4
16
4,729
4 Jan 2023
We are looking for a medical doctoral student who is keen on studying #mait cells in #hbv infection @tum in collaboration with @ProtzerLab! Please apply via email to katrin.boettcher [at] mri.tum.de.
1
2
9
2,839
21 Nov 2022
🟪NEW Article in press❕
A thermostable therapeutic vaccine is able to break immune tolerance in a mouse model of chronic #hepatitisB
🔓#OpenAccess at👉bit.ly/3slWPq7
@ProtzerLab
#LiverTwitter
1
4
7 Nov 2022
We are proud @TherVacB_EU to be further investigating the #therapeutic #vaccine in a #clinicaltrial with our partners including @ProtzerLab in Europe and Tanzania.🥼🩺🧪🌍
ℹ️thervacb.eu/the-project/
#LiverTwitter @NoHep @ICE_HBV
27 Oct 2022
𝗧𝗵𝗲𝗿𝗩𝗮𝗰𝗕 – 𝗮 𝗻𝗲𝘄 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 is a promising therapeutic option to cure chronic #hepatitisB. However, the #vaccines must be heat-stable.
💪Check what a team of researchers identified: helmholtz-munich.de/en/newsr…
#ColdChain
ALT 𝗧𝗵𝗲𝗿𝗩𝗮𝗰𝗕 – 𝗮 𝗻𝗲𝘄 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 Therapeutic vaccination is a promising therapeutic option for chronic hepatitis B patients that may allow them to cure chronic hepatitis B. However, the vaccines must be heat-stable, especially in low- and middle-income countries or hard-to-reach areas. A team of researchers around Prof Ulrike Protzer from Helmholtz Munich and Technical University of Munich (TUM) now identified an optimal formulation to maintain the stability of HBV vaccine components. The results are published in the Journal of Hepatology Reports. TherVacB will be evaluated in a clinical trial starting in 2023 and conducted in Europe and Africa.
2
7 Nov 2022
📢Important 📰from @ProtzerLab team out about how thermostable components can be cooled during transport and storage to reduce costs and ease application of a well-tolerated #therapeutic #cure vaccine for #CHB patients worldwide🌎.
➡️cutt.ly/Thermostable-HBV-vac…
#LiverTwitter
1
4